KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ClearPoint Neuro (CLPT) Research & Development (2018 - 2025)

ClearPoint Neuro (CLPT) has disclosed Research & Development for 13 consecutive years, with $3.2 million as the latest value for Q4 2025.

  • Quarterly Research & Development fell 2.85% to $3.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $13.9 million through Dec 2025, up 12.14% year-over-year, with the annual reading at $13.9 million for FY2025, 12.14% up from the prior year.
  • Research & Development hit $3.2 million in Q4 2025 for ClearPoint Neuro, down from $3.5 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $3.8 million in Q2 2025 to a low of $1.6 million in Q1 2021.
  • Historically, Research & Development has averaged $2.9 million across 5 years, with a median of $3.0 million in 2022.
  • Biggest five-year swings in Research & Development: surged 159.73% in 2021 and later dropped 13.45% in 2024.
  • Year by year, Research & Development stood at $3.1 million in 2021, then dropped by 4.75% to $2.9 million in 2022, then fell by 9.4% to $2.7 million in 2023, then increased by 25.64% to $3.3 million in 2024, then decreased by 2.85% to $3.2 million in 2025.
  • Business Quant data shows Research & Development for CLPT at $3.2 million in Q4 2025, $3.5 million in Q3 2025, and $3.8 million in Q2 2025.